Skip to main content
. Author manuscript; available in PMC: 2019 Apr 19.
Published in final edited form as: Clin Pharmacol Biopharm. 2017 May 18;6:170. doi: 10.4172/2167-065X.1000170

Table 2:

Comparison of study parameters between the two treatment groups. In brackets: Values in healthy control subjects.

Anti-ox-LDL EU/mL
(18.2 ± 3.4)
Entry 6 months 12 months 21 months 24 months
FPP 28.1 ± 10.2 28.2 ± 9.3 21.4± 14.5* 21.2± 10.7* 20.5± 7.9*
AntiOx mixture 26.8 ± 12.9 27.1 ± 8.8 27.4± 6.4 26.9± 13.3 25,7± 16.1
*

p<0.05 vs. baseline and vs. Antioxidant cocktail.